secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2026-06-29T20:19:53+00:00
Accession:  0001819790-26-000043
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus shareholders elect four Class III directors, approve exec comp, ratify auditor
--------------------------------------------------------------------------------

- Wendy Yarno, Andrew Goldberg, Scott Morrison, David Pyott elected as Class III directors.
- Advisory vote on named executive officer compensation approved with 34.5M for, 0.24M against.
- Ratification of Ernst & Young as independent auditor for FY2026 approved with 38.2M for.
- Meeting held June 25, 2026; 38.2M shares voted out of 43.0M outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979026000043/0001819790-26-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979026000043/tars-20260625.htm
  HTML page:      https://secwatch.observer/filing/0001819790-26-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer